Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
Posted inHematology Frontier

From across the globe, distinguished researchers are presenting their findings at the European Hematology Association (EHA) Congress, illuminating new pathways in hematology.

Posted by By Mourabit Halima 2025.03.05Posted inHematology Frontier0 Shares
Home » From across the globe, distinguished researchers are presenting their findings at the European Hematology Association (EHA) Congress, illuminating new pathways in hematology.

Post Views: 278

Share via:

  • Facebook
  • X (Twitter)
  • LinkedIn
  • More
Mourabit Halima
View All Posts

Post navigation

Previous Post
Renowned international scholars gather at the European Hematology Association (EHA) Congress, sharing groundbreaking insights and fostering global collaboration in the field of hematology. Renowned international scholars gather at the European Hematology Association (EHA) Congress, sharing groundbreaking insights and fostering global collaboration in the field of hematology.
Next Post
At the European Hematology Association (EHA) congress , Professor Richard Van Wijk from the University Medical Center Utrecht delivered a captivating presentation titled “Activation of pyruvate kinase as a therapeutic option for rare hemolytic anemias.” At the European Hematology Association (EHA) congress , Professor Richard Van Wijk from the University Medical Center Utrecht delivered a captivating presentation titled “Activation of pyruvate kinase as a therapeutic option for rare hemolytic anemias.”
  • LinkedIn
  • Twitter
  • Mail
Related Media:
Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
Media Medic Publishing Company Limited(HK)
赛美出版有限公司(香港)
Scroll to Top
  • Facebook
  • X (Twitter)
  • LinkedIn
  • More Networks
Share via
Facebook
X (Twitter)
LinkedIn
Mix
Email
Print
Copy Link
Copy link
CopyCopied